期刊文献+

IFN-γ和IL-6对多发性骨髓瘤B淋巴细胞刺激因子表达变化的调控研究 被引量:2

Regulation of B-lymphocyte stimulator expression levels in response to IFN-γ and IL-6
原文传递
导出
摘要 目的探讨IFN-γ和IL-6对多发性骨髓瘤(multiple myeloma,MM)B淋巴细胞刺激因子(BLyS)表达变化的影响及相关机制。方法采用流式细胞术、实时荧光定量PCR、ELISA及Western blot方法分析人MM肿瘤细胞KM3在IFN-γ和IL-6以及相关信号通路特异性抑制剂作用前后BLyS表达水平的变化。结果IFN-γ和IL-6促进KM3细胞BLyS的表达水平;NF—κB抑制剂能够抑制BLyS的表达水平;NF—κB抑制剂BAY11-7082能够完全下调IFN-γ引起的BLyS表达的上调作用;抑制促分裂原活化蛋白激酶(MAPK)的活性能够下调BLyS的表达水平。结论MAPK与NF—κB信号通路参与了BLyS的表达调节。 Objective To investigate the regulation of B-lymphocyte stimulator(BLyS) levels in response to IFN-γand IL-6. Methods Flow cytometry, quantitative polymerase chain reaction, ELISA and Western blot were applied to examine the expression level of BLyS in response to IFN-γand IL-6 . Results IFN-γ and IL-6 induced BLyS expression in KM3 cells. After treated with BAY11-7082, an IKB-α phosphorylation inhibitor, the up regulation of BLyS induced by IFN-γ was completely inhibited. Inhibiting the nuclear factor-κB (NF-κB) and mitogen activated protein kinase (MAPK) activation in KM3 cells reduced BLyS protein and gene expression. Conclusion MAPK and NF-κB pathways are involved in the regulation of BLyS expression, which suggests that MAPK and NF-κB might be used for the treatment of multiple myeloma.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2009年第4期351-355,共5页 Chinese Journal of Microbiology and Immunology
基金 江苏省医学重点建设学科资助(XK200723) 南通市社会发展科技计划(S2007035)
关键词 多发性骨髓瘤 B淋巴细胞刺激因子 核转录因子ΚB 促分裂原活化蛋白激酶 Multiple myeloma B-lymphocyte stimulator Nuclear factor-κB Mitogen activated protein kinase
  • 相关文献

参考文献11

  • 1Moore PA, Belvedere O, Orr A, et al. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science, 1999, 285(5425): 260-263.
  • 2Schneider P, MacKay F, Steiner V, et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med, 1999, 189(11): 1747-1756.
  • 3Novak A J, Bram R J, Kay NE, et al. Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival. Blood, 2002, 100(8) : 2973-2979.
  • 4Ju S, Zhang D, Wang Y, et al. Correlation of the expression levels of BLyS and its receptors mRNA in patients with systemic lupus erythematosus. Clin Biochem, 2006, 39(12) : 1131-1137.
  • 5Scapini P, Nardelli B, Nadali G, et al. G-CSF-stimulated neutrophils are a prominent source of functional BLyS. J Exp Med, 2003, 197(3) : 297-302.
  • 6Gras MP, Laabi Y, Linares-Cruz G, et al. BCMA: an integral membrane protein in the Golgi apparatus of human mature B lymphocytes. Int Immunol, 1995, 7(7) : 1093-1106.
  • 7Adachi Y, Yoshio-Hoshino N, Nishimoto N. The blockade of IL-6 signaling in rational drug design. Curt Pharm Des, 2008, 14 (12) : 1217-1224.
  • 8Nardelli B, Belvedere O, Roschke V, et al. Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood, 2001, 97 ( 1 ) : 198-204.
  • 9Cilloni D, Martinelli G, Messa F, et al. Nuclear factor-κB as a target for new drug development in myeloid malignancies. Haematologica, 2007, 92(9) : 1224-1229.
  • 10Colcombet J, Hirt H. Arabidopsis MAPKs: a complex signalling network involved in multiple biological processes. Biochem J, 2008, 413(2) : 217-226.

同被引文献41

  • 1Moore PA, Belvedere O, Orr A, et al. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science, 1999, 285 (5425) : 260-263.
  • 2Schneider P, MacKay F, Steiner V, et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med, 1999, 189(11): 1747-1756.
  • 3Thompson JS, Bixler SA, Qian F, et al. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science, 2001, 293(5537) : 2108-2111.
  • 4Briones J, Timmerman JM, Hilbert DM, et al. BLyS and BLyS receptor expression in non-Hodgkin's lymphoma. Exp Hematol, 2002, 30(2) : 135-141.
  • 5Fu L, Lin-Lee YC, Pham LV, et al. Constitutive NF-kappaB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas. Blood, 2006, 107 ( 11 ) : 4540- 4548.
  • 6Ju S, Zhang D, Wang Y, et al. Correlation of the expression levels of BLyS and its receptors mRNA in patients with systemic lupus erythematosus. Clin Biochem, 2006, 39(12): 1131-1137.
  • 7Yuan H, Wang Y, Wu X, et al. Characterization of the 5'-flanking region and regulation of transcription of human BAFF-R gene. DNA Cell Biol, 2010, 29(3) : 133-139.
  • 8Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol, 2002, 2(10) : 725-734.
  • 9Xiao W, Hodge DR, Wang L, et al. NF-kappaB activates IL-6 expression through cooperation with c-Jun and IL6-AP1 site, but is independent of its IL6-NF kappaB regulatory site in autocrine human multiple myeloma cells. Cancer Biol Ther, 2004, 3 (10): 1007-1017.
  • 10Wada K, Maeda K, Tajima K, et al. Expression of BAFF-R and TACI in reactive lymphoid tissues and B-cell lymphomas. Histopathology, 2009, 54(2) : 221-232.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部